Overcoming AAV Manufacturing Challenges

Since inception, the Center for Breakthrough Medicines has actively aligned with partners across the industry to develop more knowledge and understanding of the challenges, existing solutions, and future potential solutions for advancing novel therapies. The goal is to build a toolbox of technologies and services around the critical quality attributes that impact the efficacy, safety, and stability of next-generation medicines that will allow rapid development and commercialization of advanced technologies such as AAV vectors for gene therapy.

Read full story